Dana Hocková Selected Research

hypoxanthine-guanine-xanthine phosphoribosyltransferase

7/2009

Inhibition of hypoxanthine-guanine phosphoribosyltransferase by acyclic nucleoside phosphonates: a new class of antimalarial therapeutics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dana Hocková Research Topics

Disease

3	Parasitemia 09/2015 - 01/2011
2	Parasitic Diseases (Parasitic Disease) 12/2019 - 01/2018
1	Neoplasms (Cancer) 09/2022
1	Leukemia 09/2022
1	African Trypanosomiasis (Nagana) 12/2021
1	Carcinoma (Carcinomatosis) 07/2021
1	Infections 01/2021
1	Tuberculosis (Tuberculoses) 11/2020
1	Malaria 07/2009

Drug/Important Bio-Agent (IBA)

3	ProdrugsIBA 09/2022 - 09/2015
3	Hypoxanthine Phosphoribosyltransferase (Hypoxanthine Guanine Phosphoribosyltransferase)IBA 01/2021 - 01/2012
2	NucleotidesIBA 12/2021 - 07/2009
2	purineIBA 12/2021 - 07/2009
2	Chloroquine (Aralen)FDA LinkGeneric 07/2021 - 09/2015
2	Pharmaceutical PreparationsIBA 01/2021 - 12/2019
2	NucleosidesIBA 01/2012 - 01/2011
2	Organophosphonates (Phosphonates)IBA 01/2012 - 01/2011
2	EnzymesIBA 01/2011 - 07/2009
1	PurinesIBA 12/2021
1	phosphoramidic acidIBA 07/2021
1	XanthineIBA 01/2021
1	GuanineIBA 01/2021
1	Antimalarials (Antimalarial Agents)IBA 01/2018
1	Purine NucleosidesIBA 01/2012
1	CarbonIBA 01/2011
1	hypoxanthine-guanine-xanthine phosphoribosyltransferaseIBA 07/2009
1	Nucleic AcidsIBA 07/2009